US-guided high-intensity focused ultrasound (HIFU) of abdominal tumors: outcome, early ablation-related laboratory changes and inflammatory reaction. A single-center experience from Germany

References

• Wu F, Wang Z-B, Chen W-Z, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem. 2004;11(3–4):149–154.
   PubMed Web of Science ®Google Scholar
• Xiong LL, Hwang JH, Huang XB, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP. 2009;10(2):123–129.
   PubMedGoogle Scholar
• Marinova M, Huxold H, Henseler J, et al. Clinical effectiveness and potential survival benefit of us-guided high-intensity focused ultrasound therapy in patients with advanced-stage pancreatic cancer. Ultraschall in Der Medizin – Euro J Ultrasound. 2019;40(05):625–637.
   Google Scholar
• Marinova M, Wilhelm-Buchstab T, Strunk H. Advanced pancreatic cancer: high-intensity Focused Ultrasound (HIFU) and other local ablative therapies. Rofo. 2019;191(3):216–227.
   PubMedGoogle Scholar
• Lyon PC, Rai V, Price N, et al. Ultrasound-guided high intensity focused ultrasound ablation for symptomatic uterine fibroids: preliminary clinical experience. Ultraschall Med. 2020;41(05):550–556.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Pelloni F, Bini F, et al. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results. Endocrine. 2019;65(2):312–317.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang Z-B, Cao Y-D, et al. “Wide local ablation” of localized breast cancer using high intensity focused ultrasound. J Surg Oncol. 2007;96(2):130–136.
   PubMed Web of Science ®Google Scholar
• Li Y-Y, Sha W-H, Zhou Y-J, et al. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22(12):2148–2154.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhou K, Zhang L, et al. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection. Eur J Radiol. 2009;72(1):160–166.
   PubMed Web of Science ®Google Scholar
• Klatte T, Kroeger N, Zimmermann U, et al. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol. 2014;32(3):597–605.
   PubMed Web of Science ®Google Scholar
• Hsiao Y-H, Kuo S-J, Tsai H-D, et al. Clinical application of high-intensity focused ultrasound in cancer therapy. J Cancer. 2016;7(3):225–231.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Wang Y-N, Warren C, et al. Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol. 2009;35(6):967–975.
   PubMed Web of Science ®Google Scholar
• Orsi F, Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol. 2010;195(3):W245–52.
   PubMed Web of Science ®Google Scholar
• Marinova M, Rauch M, Mücke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26(11):4047–4056.
   PubMed Web of Science ®Google Scholar
• Elhelf IAS, Albahar H, Shah U, et al. High intensity focused ultrasound: the fundamentals, clinical applications and research trends. Diagn Interv Imaging. 2018;99(6):349–359.
   PubMed Web of Science ®Google Scholar
• Osada S, Imai H, Tomita H, et al. Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol. 2007;95(6):491–498.
   PubMed Web of Science ®Google Scholar
• Jansen MC, van Wanrooy S, van Hillegersberg R, et al. Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors. Eur J Surg Oncol. 2008;34(6):662–667.
   PubMed Web of Science ®Google Scholar
• van den Bijgaart RJE, Eikelenboom DC, Hoogenboom M, et al. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 2017;66(2):247–258.
   PubMed Web of Science ®Google Scholar
• Waitz R, Solomon SB, Petre EN, et al. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer Res. 2012;72(2):430–439.
   PubMed Web of Science ®Google Scholar
• Dong BW, Zhang J, Liang P, et al. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia. 2003;19(2):119–133.
   PubMed Web of Science ®Google Scholar
• Fietta AM, Morosini M, Passadore I, et al. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol. 2009;70(7):477–486.
   PubMed Web of Science ®Google Scholar
• He C, Wang J, Sun S, et al. Immunomodulatory effect after irreversible electroporation in patients with locally advanced pancreatic cancer. J Oncol. 2019;2019:9346017.
   PubMed Web of Science ®Google Scholar
• Slovak R, Ludwig JM, Gettinger SN, et al. Immuno-thermal ablations – boosting the anticancer immune response. j Immunotherapy Cancer. 2017;5(1):78.
   PubMed Web of Science ®Google Scholar
• Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58(1):1–11.
   PubMed Web of Science ®Google Scholar
• Ahmad F, Gravante G, Bhardwaj N, et al. Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg. 2010;200(4):500–506.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun J. High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J. 2002;115(9):1332–1335.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang Z-B, Lu P, et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004;30(9):1217–1222.
   PubMed Web of Science ®Google Scholar
• Xu Z-L, Zhu X-Q, Lu P, et al. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer. Ultrasound Med Biol. 2009;35(1):50–57.
   PubMed Web of Science ®Google Scholar
• Haen SP, Pereira PL, Salih HR, et al. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011;2011:160250.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang Y, Feng J, et al. Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses. Ultrasound Med Biol. 2010;36(3):441–448.
   PubMed Web of Science ®Google Scholar
• Ito F, Ku AW, Bucsek MJ, et al. Immune adjuvant activity of pre-resectional radiofrequency ablation protects against local and systemic recurrence in aggressive murine colorectal cancer. PLoS One. 2015;10(11):e0143370.
   PubMed Web of Science ®Google Scholar
• Sabel MS, Su G, Griffith KA, et al. Rate of freeze alters the immunologic response after cryoablation of breast cancer. Ann Surg Oncol. 2010;17(4):1187–1193. Apr
   PubMed Web of Science ®Google Scholar
• Alteber Z, Azulay M, Cafri G, et al. Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity. Cancer Immunol Immunother. 2014;63(4):369–380.
   PubMed Web of Science ®Google Scholar
• Chen Z, Shen S, Peng B, et al. Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model. Int J Hyperthermia. 2009;25(5):374–382.
   PubMed Web of Science ®Google Scholar
• Ringel-Scaia VM, Beitel-White N, Lorenzo MF, et al. High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity. EBioMedicine. 2019;44:112–125.
   PubMed Web of Science ®Google Scholar
• Kim H, Park BK, Kim CK. Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma. Korean J Radiol. 2008;9(5):470–472.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Xu Z, et al. Focused ultrasound: tumour ablation and its potential to enhance immunological therapy to cancer. Br J Radiol. 2018;91(1083):20170641
   PubMed Web of Science ®Google Scholar
• Schälte G, Henzler D, Waning C, et al. Case study of hepatic radiofrequency ablation causing a systemic inflammatory response under total intravenous anesthesia. Korean J Radiol. 2010;11(6):640–647.
   PubMed Web of Science ®Google Scholar
• Erinjeri JP, Thomas CT, Samoilia A, et al. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. J Vasc Interv Radiol. 2013;24(8):1105–1112.
   PubMed Web of Science ®Google Scholar
• Evrard S, Menetrier-Caux C, Biota C, et al. Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases. Gastroenterol Clin Biol. 2007;31(2):141–145.
   PubMedGoogle Scholar
• Wang X, Qin J, Chen J, et al. The effect of high-intensity focused ultrasound treatment on immune function in patients with uterine fibroids. Int J Hyperthermia. 2013;29(3):225–233.
   PubMed Web of Science ®Google Scholar
• Long KB, Tooker G, Tooker E, et al. IL6 receptor blockade enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2017;16(9):1898–1908.
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y, et al. Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun. 2005;335(1):124–131.
   PubMed Web of Science ®Google Scholar
• Kramer G, Steiner GE, Gröbl M, et al. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate. 2004;58(2):109–120.
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007;5:34.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhu X-Q, Zhang J, et al. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment. Ultrasound Med Biol. 2008;34(1):81–87.
   PubMed Web of Science ®Google Scholar
• Schueller G, Kettenbach J, Sedivy R, et al. Expression of heat shock proteins in human hepatocellular carcinoma after radiofrequency ablation in an animal model. Oncol Rep. 2004;12(3):495–499.
   PubMed Web of Science ®Google Scholar
• Schneider T, Hoffmann H, Dienemann H, et al. Immune response after radiofrequency ablation and surgical resection in nonsmall cell lung cancer. Semin Thorac Cardiovasc Surg. 2016;28(2):585–592.
   PubMed Web of Science ®Google Scholar
• Hu ZI, McArthur HL, Ho AY. The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer? Curr Breast Cancer Rep. 2017;9(1):45–51.
   PubMed Web of Science ®Google Scholar
• Rao P, Escudier B, de Baere T. Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Intervent Radiol. 2011;34(2):424–430.
   PubMed Web of Science ®Google Scholar
• Ghodadra A, Bhatt S, Camacho JC, et al. Abscopal effects and yttrium-90 radioembolization. Cardiovasc Intervent Radiol. 2016;39(7):1076–1080.
   PubMed Web of Science ®Google Scholar
• Hans-Christian K, Cornelia K-L. High focused ultrasound in a case of previously untreated breast cancer. Clin Med Rev Case Rep. 2019;6(2):28.
   Google Scholar
• Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol. 2012;3(2):105–119.
   PubMedGoogle Scholar
• Li Y-J, Huang G-L, Sun X-L, et al. The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma. World J Surg Oncol. 2016;14:60.
   PubMed Web of Science ®Google Scholar
• D’Onofrio M, Barbi E, Girelli R, et al. Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma. J Gastrointest Oncol. 2016;7(2):213–220.
   PubMed Web of Science ®Google Scholar
• Meng Q, Shi S, Liang C, et al. Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. Onco Targets Ther. 2017;10:4591–4598.
   PubMed Web of Science ®Google Scholar
• Ghanamah M, Berber E, Siperstein A. Pattern of carcinoembryonic antigen drop after laparoscopic radiofrequency ablation of liver metastasis from colorectal carcinoma. Cancer. 2006;107(1):149–153.
   PubMed Web of Science ®Google Scholar